Context Therapeutics Inc. – Filings and Transcripts

NASDAQ: CNTX
Share price (9/24/26): $0.37
Market cap (9/24/26): $34.1 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Registration of securities for employees

Prospectus supplement for primary offering

Shelf registration

Ownership Filter

MPM BioImpact LLC

Blue Owl Capital Holdings LP

Octagon Capital Advisors LP

News Filter

Investor Presentation

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Announces Positive Interim Efficacy and Safety Results From Ongoing Phase 1 Clinical Trial for CTIM-76

Enters Into License Agreement Amendment With BioAtla for CT-202

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC